Pancreatic Cancer Research

ResearcherSpectrum HealthActive in the last 2 years

Hordur Mar Kolbeinsson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9076-9280; OpenAlex author ID A5066918840. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. First author DOI 10.1177/00031348241250043↗
  2. Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. Co-author DOI 10.1080/08941939.2022.2129884↗
  3. Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2020.06.042↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gerald Paul Wright · 3 shared papers, 2021–2024 · strength 0.62
  2. Mathew H. Chung · 3 shared papers, 2021–2024 · strength 0.62
  3. Sreenivasa Rao Chandana · 2 shared papers, 2023–2024 · strength 0.48
  4. M. Mura Assifi · 2 shared papers, 2021–2024 · strength 0.35
  5. Jesse K. Kelley · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.